Figure 6.
The hepatitis C NS3 protease inhibitor BILN 2061 21 is based on a 15-membered RCM-derived tripeptide macrocycle (highlighted in red) and showed great promise in phase I clinical trials, but eventually did not make it to the market.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.